Lim et al. [8] demonstrated the direct effect of chronic insulin treatment on GLP-1 secretion showing that an induced state of insulin resistance was able to markedly reduce the activation of both AKT and ERK1/2 [8]. The gene discussed is MAPK3; the disease is Insulin resistance.